Wnt-targeted hair loss treatment

Mirae Asset Global Investments Co. is set to manage the mandate of more than 600 billion won ($416.8 million) in core real estate fund investment by...

Meritz Financial Group Inc., one of South Korea’s most aggressive alternative asset managers, has committed 150 billion won ($105 million) to ...

South Korea’s National Pension Service, the country’s largest institutional investor, has come to the rescue of the domestic stock marke...

Kia Corp., South Korea’s second-largest carmaker, will build an electric pickup model tailored for North America to enter the world’s la...

Kakao Entertainment Corp. has been divesting unprofitable music labels and digital content platforms, which it has gobbled up over the past few year...

The Korean Teachers’ Credit Union (KTCU) achieved an 11.1% return on investments in 2024, with overseas portfolios in stocks, infrastructure a...

Hyundai Motor Group Chairman Chung Euisun has set an ambitious target to outpace Tesla Inc. in software-defined vehicle (SDV) technology by 2028, un...

Samsung Electronics Co. Chairman Lee Jae-yong has warned the company's executives that the South Korean tech giant has lost its characteristic "rele...

Chinese stocks are attracting South Korean investors looking beyond Wall Street amid the downturn in US Big Tech stocks.South Korea’s equity f...

South Korea’s National Pension Service (NPS), the nation’s biggest institutional investor, could lose more than 1 trillion won ($692 mil...

South Korea’s foreign exchange reserves diminished to the lowest level in nearly five years last month, largely due to the expanded forex swap...

Mirae Asset Global Investments Co. is set to introduce the world’s first passive target-date exchange-traded fund (ETF) this month to attract ...

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

South Korean institutional investors, including banks, insurers and securities companies, have yet to fully benefit from recent declines in bond yie...

EQT, the largest private equity firm in Europe, is setting its sights on healthcare, technology companies and business service providers in South Ko...

PAG, an Asia Pacific-focused alternative investment firm, on Friday announced the final close of its 10th opportunistic real estate fund at $4 billi...

SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...

Small and medium-sized enterprises (SMEs) accounted for the majority of disputes over corporate management control in South Korea last year, with th...

LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

South Korean venture capital firm Partners Investment said on Thursday it will raise up to 215.5 billion won ($150 million) in a biotech fund jointl...

SK Hynix Inc., the top supplier of high-bandwidth memory (HBM) chips to Nvidia Corp., on Thursday reported its highest-ever quarterly profit of 8.08...

South Korea’s Hanwha Aerospace Co. is close to signing a 400 billion won ($276 million) deal to export as many as 30 units of the K9 Thunder s...

LG Energy Solution Ltd. reported its first quarterly loss in more than three years on Thursday, adding to concerns that the world’s third-larg...

Hyundai Motor Co. and its sibling Kia Corp. have set a target to sell a combined 7.39 million units around the globe this year with greater focus on...

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

South Korea’s central bank chief said on Wednesday the impact of political turmoil caused by martial law on Asia’s fourth-largest econom...

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...